Voltage-dependent N-type calcium channel subunit alpha-1B — Drug Target

All drugs that target Voltage-dependent N-type calcium channel subunit alpha-1B — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

lomerizine

Phase 2 pipeline (1)

• LOMERIZINE · lomerizine · Neuroscience
  Lomerizine works by blocking calcium channels in the brain to reduce excessive neuronal activity.